iFabric Corp. (IFA:TSX)
FA has developed a technological application for medical scrubs that provides reduced bacterial/ pathogen proliferation on scrubs, confirmed by a peer-reviewed clinical trial.
The Company is significantly growing its retail footprint through major distribution partners, including a 1,000-store Walmart rollout in the US, 400-stores with Target in the US, and launch with Costco in Canada. This represents only a fraction of the potential locations.
The medical scrubs market is expected to grow at a 9.4% CAGR through 2032, supported by a growing U.S. healthcare workforce, post-COVID mandates, and the PFAS regulatory phase-out.
In 2025, IFA grew revenue 20% YoY to $32.9M, with the Intelligent Fabric division growing 33% YoY. We expect a large acceleration, with revenue growth of 94% in 2026 and 41% in 2027.
Management and insiders own approximately 53% of the Company, creating strong alignment with shareholder interests.
Investment Summary
iFabric develops, licenses, and commercializes innovative performance technologies for textiles and apparel. Through its Intelligent Fabric Technologies (North America) division, iFabric partners with global brands and retailers to deliver enhanced fabric functionality ranging from antimicrobial technologies to moisture management and PFAS-free water repellency—across diverse end uses.
Company Description
Research
